Beam sues 2 biotechs, alleging theft of base editing trade secrets
Published . Updated .
Beam claimed a former scientist stole confidential information and quietly spun up a rival rare disease treatment at YolTech Therapeutics. Serapha Bio, which licensed that therapy, denies the charges.
Directly affected
- No company is named in this report.
Indirectly affected
- FBT First Trust NYSE Arca Biotech ETF
GA selected FBT as a RELATED security because its canonical security name directly matches this event's themes: biotechs. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- XBIX CORGI ETF TR I U S BIOTECH 2X
GA selected XBIX as a RELATED security because its canonical security name directly matches this event's themes: biotechs. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Beam claimed a former scientist stole confidential information and quietly spun up a rival rare disease treatment at YolTech Therapeutics. Serapha Bio, which licensed that therapy, denies the charges.
Source: BioPharma Dive
First Trust NYSE Arca Biotech ETF (FBT) since this story, compared with the market
Since the first closing price after “Beam sues 2 biotechs, alleging theft of base editing trade secrets,” First Trust NYSE Arca Biotech ETF (FBT) is -2.63%. The S&P 500 fund (SPY) is +0.56% over the same days, a -3.19% difference versus the market.
Who gains and who loses around First Trust NYSE Arca Biotech ETF (FBT)
Companies carried with this story
- FBT First Trust NYSE Arca Biotech ETF
For “Beam sues 2 biotechs, alleging theft of base editing trade secrets,” First Trust NYSE Arca Biotech ETF (FBT) is linked, with no stored direction, medium confidence. Reason on file: GA selected FBT as a RELATED security because its canonical security name directly matches this event's themes: biotechs. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- XBIX Corgi Etf Tr I U S Biotech 2X
For “Beam sues 2 biotechs, alleging theft of base editing trade secrets,” Corgi Etf Tr I U S Biotech 2X (XBIX) is linked, with no stored direction, medium confidence. Reason on file: GA selected XBIX as a RELATED security because its canonical security name directly matches this event's themes: biotechs. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
First Trust NYSE Arca Biotech ETF (FBT)
“Beam sues 2 biotechs, alleging theft of base editing trade secrets” (29 Sep 2026) reaches First Trust NYSE Arca Biotech ETF (FBT) through this story.
What ties First Trust NYSE Arca Biotech ETF (FBT) to the headline is this: GA selected FBT as a RELATED security because its canonical security name directly matches this event's themes: biotechs. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Also listed, Corgi Etf Tr I U S Biotech 2X (XBIX): GA selected XBIX as a RELATED security because its canonical security name directly matches this event's themes: biotechs. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates and price levels for First Trust NYSE Arca Biotech ETF (FBT)
FBT traded between 256.21 and 275.01 across 20 sessions. The latest close on file is 265.38. XBIX traded between 31.99 and 37.71 across 6 sessions. The latest close on file is 31.99.
What the saved facts support for First Trust NYSE Arca Biotech ETF (FBT)
21 out of 100
“Beam sues 2 biotechs, alleging theft of base editing trade secrets” scores 21 out of 100. The score uses 1 sources, and 2 linked companies.